A Multicenter, Open-label, Phase 2 Study of VELCADE (bortezomib) for Injection in Previously Treated Patients with Stage IIIB and IV Bronchioloalveolar Carcinoma and Adenocarcinoma with Bronchioloalveolar Features

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2005
This article has no abstract
Epistemonikos ID: d3a2b62a62f21afa3caa45f4222e29480ba97781
First added on: Jan 21, 2025